These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16097596)

  • 1. [Cardiac sarcoidosis detected by FDG-PET].
    Goto K; Okamoto E; Morita M; Sasamoto T; Endo M; Umezawa K; Suguta M; Kaneko Y; Nakano A; Arai M; Hasegawa A; Kurabayashi M
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1396-8. PubMed ID: 16097596
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
    Higuchi Y; Kimoto Y; Tanoue R; Tokunou T; Tomonari K; Maeda T; Horiuchi T
    Intern Med; 2018 Jun; 57(11):1601-1604. PubMed ID: 29321427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.
    Mc Ardle BA; Leung E; Ohira H; Cocker MS; deKemp RA; DaSilva J; Birnie D; Beanlands RS; Nery PB
    J Nucl Cardiol; 2013 Apr; 20(2):297-306. PubMed ID: 23288545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
    Smedema JP; White L; Klopper AJ
    Cardiovasc J Afr; 2008; 19(6):309-10. PubMed ID: 19104727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint SNMMI-ASNC expert consensus document on the role of
    Chareonthaitawee P; Beanlands RS; Chen W; Dorbala S; Miller EJ; Murthy VL; Birnie DH; Chen ES; Cooper LT; Tung RH; White ES; Borges-Neto S; Di Carli MF; Gropler RJ; Ruddy TD; Schindler TH; Blankstein R
    J Nucl Cardiol; 2017 Oct; 24(5):1741-1758. PubMed ID: 28770463
    [No Abstract]   [Full Text] [Related]  

  • 6. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
    Györik S; Ceriani L; Menafoglio A; Gallino A; Wyttenbach R
    Thorax; 2007 Jun; 62(6):560. PubMed ID: 17536038
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
    Paz YE; Bokhari S
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac FDG/PET imaging mimicking sarcoidosis.
    Lai JKC; Teo E; Lichtenstein M; Toh HB; Sivaratnam D
    J Nucl Cardiol; 2019 Jun; 26(3):1025-1027. PubMed ID: 30627883
    [No Abstract]   [Full Text] [Related]  

  • 10. Early detection of cardiac sarcoidosis: comparison of 18F-FDG PET with 11C-choline PET.
    Miwa S; Inui N; Suda T; Miyazaki H; Torizuka T; Chida K
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):156-8. PubMed ID: 18496990
    [No Abstract]   [Full Text] [Related]  

  • 11. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
    Brancato SC; Arrighi JA
    J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator.
    Casset-Senon D; Philippe L; Renard JP; Cosnay P
    J Nucl Cardiol; 2008; 15(2):282-5. PubMed ID: 18371601
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
    Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
    Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
    Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.
    Van Schandevyl S; Waterschoot R; De Vos N; Devos D; Goethals I
    J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):335-336. PubMed ID: 31809284
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis.
    Alvi RM; Young BD; Shahab Z; Pan H; Winkler J; Herzog E; Miller EJ
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1284-1287. PubMed ID: 30846271
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.
    Martineau P; Pelletier-Galarneau M; Juneau D; Leung E; Nery PB; de Kemp R; Beanlands R; Birnie D
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2280-2281. PubMed ID: 31422126
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac sarcoidosis after glucocorticoid therapy evaluated by
    Kiko T; Masuda A; Nemoto A; Tominaga H; Oriuchi N; Yoshihisa A; Takeishi Y
    J Nucl Cardiol; 2018 Apr; 25(2):685-687. PubMed ID: 28913789
    [No Abstract]   [Full Text] [Related]  

  • 20. False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis.
    Gonzalez WO; Massera D; Travin MI
    J Nucl Cardiol; 2015 Dec; 22(6):1323-5. PubMed ID: 25762035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.